Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

3
WA bid to lift mining enrolment numbers

2018-07-20 perthnow.com.au
THE WA mining industry has come together in a “call to arms” after successive cohorts of school leavers ignored the industry on which the State has built its reputation.
RIO RIO NSRPF SCEXF NVO IGO IIDDY FSUGY RTPPF FSUMF RIO RTNTF FMG WNARF WSA SAR

2
Macarthur Minerals Update on the Exploration and Development of Its Iron Ore, Gold, Nickel and Lithium Projects

2018-07-17 globenewswire
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Macarthur Minerals Limited (TSX-V:MMS) (the “Company” or “Macarthur”) is pleased to provide an update to Shareholders outlining an active second quarter 2018 in the ongoing development of the Company’s iron ore projects and exploration activities across the lithium, gold and nickel/cobalt projects in Western Australia and Nevada, USA.
RTPPF RIO RIO FSUMF RIO MMSDF RTNTF FMG FSUGY

5
Top-grade iron ore may spike to $100

2018-07-16 bworldonline
High-grade iron ore may spike to $100 a metric ton as China intensifies a clampdown on pollution by restraining industrial activity, adding further momentum to a trend that’s reshaped the global market in recent years and driven buyers in Asia’s top economy seek out better-quality material.
C.WSA BLT C C.PRL VALE3 C.PRJ BHPBF C.PRK C.PRG C.PRC FSUGY C.WS.B FSUMF BHP C.PRPCL CGBBW C.WS.A C.PRP BBL BHP C.PRU FMG BHPLF C.PRS

0
'Fair and reasonable': Rinehart bid for Atlas receives boost

2018-07-16 theage.com.au
The $390 million offer by the Gina Rinehart camp for Atlas Iron has been declared “fair and reasonable” in an independent expert’s report examining the offer for the loss-making junior miner.
AGO FSUMF ATLGF AGODY MALRY FMG MALRF MIN FSUGY

0
'Fair and reasonable': Rinehart bid for Atlas receives boost

2018-07-16 smh.com.au
The $390 million offer by the Gina Rinehart camp for Atlas Iron has been declared “fair and reasonable” in an independent expert’s report examining the offer for the loss-making junior miner.
AGO FSUMF ATLGF AGODY MALRY FMG MALRF MIN FSUGY

2
WA tug company wins $200m Rio Tinto Pilbara ports contract

2018-07-11 theage.com.au
Rio Tinto has entered into a five-year $200 million contract with WA-based company Westug to provide towage services at the company’s iron operations in the Pilbara.
RTPPF RIO RIO FSUMF RIO RTNTF FMG FSUGY

2
WA tug company wins $200m Rio Tinto Pilbara ports contract

2018-07-11 smh.com.au
Rio Tinto has entered into a five-year $200 million contract with WA-based company Westug to provide towage services at the company’s iron operations in the Pilbara.
RTPPF RIO RIO FSUMF RIO RTNTF FMG FSUGY

2
Bidding war begins as WA once again searches for workers to fuel a mining boom

2018-07-10 abc.net.au
Last time the workers flew in from all over the country and abroad to earn the big money on Western Australia's iron ore mines. Companies were offering ridiculous wages and conditions.
RTPPF RIO RIO FSUMF RIO RTNTF FMG FSUGY

4
Panel dismisses FMG application

2018-07-02 businessnews.com.au
The Takeovers Panel has dismissed an application from Fortescue Metals Group questioning the veracity of Hancock Prospecting’s $390 million bid for Atlas Iron.
AGO FSUMF ATLGF AGODY FMG FSUGY

4
I found slaves in our supply chain

2018-07-02 smh.com.au
Business support for new regulations? Unheard of. But that's exactly what business leaders just did. We unanimously supported the introduction of the Modern Slavery Bill to the Parliament last week. All of us in business face the risk of modern slavery in our supply chains – I found it in my own – and it is now widely accepted that inaction, and hiding our head in the sand, are no longer options. Modern slavery is everywhere.
FSUMF FMG FSUGY

8
Takeovers Panel clears Hancock bid for Atlas Iron

2018-07-02 australianmining.com.au
The Takeovers Panel will not take action following an application from a Fortescue Metals Group subsidiary to conduct proceedings into the takeover of Atlas Iron.
AGO FSUMF ATLGF AGODY MALRY FMG MALRF MIN FSUGY

4
Hancock Prospecting will run a comb through Atlas

2018-06-30 theage.com.au
Billionaire Gina Rinehart's Hancock Prospecting will conduct a strategic review of Atlas Iron that will include its port arrangements if it successfully acquires the miner, a new bidders statement released on Friday has revealed.
AGO FSUMF ATLGF AGODY FMG FSUGY

4
Hancock Prospecting will run a comb through Atlas

2018-06-30 smh.com.au
Billionaire Gina Rinehart's Hancock Prospecting will conduct a strategic review of Atlas Iron that will include its port arrangements if it successfully acquires the miner, a new bidders statement released on Friday has revealed.
AGO FSUMF ATLGF AGODY FMG FSUGY

8
Atlas Iron urges shareholders to accept Hancock takeover offer

2018-06-29 australianmining.com.au
Atlas Iron’s board has unanimously recommended shareholders accept Hancock Prospecting’s $390 million offer for the company in the absence of a superior offer.
AGO FSUMF ATLGF AGODY MALRY FMG MALRF MIN FSUGY

4
Atlas hopeful on port rights

2018-06-28 businessnews.com.au
The future of Atlas Iron has been further muddied today after the takeover target said the state government had indicated to media it could compromise on its policy regarding development rights at Port Hedland if either Fortescue Metals Group or Hancock Prospecting takes control of the junior miner.
AGO FSUMF ATLGF AGODY FMG FSUGY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: AA6086257